Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
18,111,561
-
Shares change
-
+725,609
-
Total reported value, excl. options
-
$1,812,508,826
-
Value change
-
+$78,053,426
-
Put/Call ratio
-
35%
-
Number of buys
-
131
-
Number of sells
-
77
-
Price
-
$100.09
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2024
272 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of 30 Sep 2024.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) had 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,111,561 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, MACQUARIE GROUP LTD, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Stephens Investment Management Group LLC, CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, and VILLERE ST DENIS J & CO LLC.
This table shows the top 239 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.